WealthPLAN Partners, LLC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 132 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
WealthPLAN Partners, LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$3,000
-57.1%
14,4350.0%0.00%
Q4 2021$7,000
-53.3%
14,4350.0%0.00%
-100.0%
Q3 2021$15,000
-28.6%
14,4350.0%0.00%0.0%
Q2 2021$21,000
-25.0%
14,4350.0%0.00%
-50.0%
Q1 2021$28,0000.0%14,4350.0%0.00%0.0%
Q4 2020$28,000
+133.3%
14,4350.0%0.00%
+100.0%
Q3 2020$12,0000.0%14,4350.0%0.00%0.0%
Q2 2020$12,000
+50.0%
14,4350.0%0.00%0.0%
Q1 2020$8,000
-57.9%
14,435
-51.0%
0.00%
-50.0%
Q4 2019$19,00029,4350.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Empery Asset Management, LP 4,262,409$2,430,0005.07%
CVI Holdings, LLC 5,171,896$2,948,0000.20%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$534,0000.18%
CVA Family Office, LLC 1,137,920$649,0000.16%
ACT CAPITAL MANAGEMENT, LLC 291,500$166,0000.12%
Cypress Capital Management LLC (WY) 196,775$112,0000.09%
Willis Investment Counsel 2,181,840$1,244,0000.06%
NTB Financial Corp 146,100$83,0000.06%
Helen Stephens Group, LLC 117,222$67,0000.05%
SRS Capital Advisors, Inc. 629,172$359,0000.05%
View complete list of AMPIO PHARMACEUTICALS INC shareholders